pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,161 catalysts · 5,159 phase readout · 2,355 8k filing · 316 pdufa · 275 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 60 catalysts2026-07-30: 13 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,355
  • pdufa316
  • earnings275
  • phase 2 completion108
  • phase 1 completion50
phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05863195: Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE3. Conditions: Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Stage IV Colorectal Cancer AJCC v8, Unresectable Colorectal Carcinoma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT04899895: Rheumatology Biorepository

    Sponsor: CorEvitas. Phase: . Conditions: Rheumatoid Arthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05897775: Coordinated Reset Deep Brain Stimulation for Essential Tremor

    Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Essential Tremor, Upper Extremity Essential Tremor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07394257: Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis

    Sponsor: Minia University. Phase: NA. Conditions: Bacterial Keratitis, Recalcitrant Infectious Keratitis, Corneal Ulcer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06295757: Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures

    Sponsor: Masonic Cancer Center, University of Minnesota. Phase: NA. Conditions: Tobacco Use, Cigarette Smoking, Nicotine Dependence

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07676201: One-year Prognostic Impact of Microcirculation Assessed by NH IMR Angio in Patients Hospitalized for Acute Myocarditis

    Sponsor: University Hospital, Grenoble. Phase: . Conditions: Myocarditis Acute

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05344001: Life After Sport: Prior Injury and Sedentary Behavior as Mechanisms of Later Poor Health

    Sponsor: Marquette University. Phase: . Conditions: Aging, Athletic Injuries, Physical Inactivity, Knee Injuries and Disorders

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07287501: Efficacy of Pain Science Education Combined With Exercise in Older Adults With Chronic Pain

    Sponsor: University of Salamanca. Phase: NA. Conditions: Chronic Pain

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07485101: Glycemic Targets During CPB in Elderly Diabetes

    Sponsor: Beijing Anzhen Hospital. Phase: NA. Conditions: Glycemic Management During CPB in Elderly Diabetic Cardiac Surgery

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02912312: Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06989281: Evaluation of a Primary Care Based Lifestyle Medicine Clinic at UAB

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Obesity and Obesity-related Medical Conditions

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05414994: Assessment of the Ocular Microbiome in Health and Disease

    Sponsor: Vanderbilt University Medical Center. Phase: . Conditions: Microbial Colonization, Eye Diseases, Ophthalmopathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05535894: Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer

    Sponsor: West Virginia University. Phase: . Conditions: Pancreatic Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07518056: Relationships Between Nomophobia Levels and Perceived Stress, Body Image and Food Addiction Among University Students

    Sponsor: Bahçeşehir University. Phase: . Conditions: Nomofobia, Body Image Disturbance, Body Image, Body Image Disorder, Eating Behavior Disorders, Food Addiction, Stress

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07567651: Citicoline and Filtration Surgery

    Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: NA. Conditions: Glaucoma Therapy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02807350: Trial of Overminus Spectacle Therapy for Intermittent Exotropia

    Sponsor: Jaeb Center for Health Research. Phase: NA. Conditions: Intermittent Exotropia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04332874: A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma, Alveolar Soft Part Sarcoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03310918: A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07396818: Kamlanoflast In Amyotrophic Lateral Sclerosis

    Sponsor: Inflammasome Therapeutics. Phase: PHASE1. Conditions: ALS (Amyotrophic Lateral Sclerosis), ALS, Neuro-Degenerative Disease, Neuro-Degenerative Diseases, Motor Neuron Disease (MND)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05186818: Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

    Sponsor: Cytokinetics. Phase: PHASE3. Conditions: Obstructive Hypertrophic Cardiomyopathy (oHCM)

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07332897: Motor Relearning Program Combined With Neck Stabilization Exercises in Subacute Stroke

    Sponsor: University of Lahore. Phase: NA. Conditions: Stroke (Subacute)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07443813: An Innovative App-based Intervention to Promote Social Connectedness and Well-being in Older Adults

    Sponsor: University of Padova. Phase: NA. Conditions: Social Isolation in Older Adults, Loneliness

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07107113: Pilates and Aerobic Training on Cardiorespiratory Fitness, Flexibility, Strength, and Muscular Power in Young Adults

    Sponsor: Universidade Estadual do Norte do Parana. Phase: NA. Conditions: Improvement of Cardiorespiratory Fitness, Flexibility, Strength and Muscle Power in Healthy Participants

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05838560: Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders

    Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Schizophrenia, Treatment Resistant Depression, Aging, Premature

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07064460: Duke Customized Aortic Aneurysm Repair With Endovascular Stent-grafts - Duke CARES Trial

    Sponsor: Chandler Long, MD. Phase: NA. Conditions: Aortic Disorders

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07681960: Success of Laryngeal Mask Airway (LMA) Insertion During Continuous Chest Compressions in Neonatal Resuscitation: A Randomized Crossover Simulation Study

    Sponsor: Kahramanmaras Sutcu Imam University. Phase: NA. Conditions: Neonatal Resuscitation, Airway Management, Asphyxia Neonatorum, Cardiopulmonary Resuscitation (CPR)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04842760: PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer

    Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: . Conditions: Platelet Disorder, Heparin-induced Thrombocytopenia, Platelet Activation, Platelet Aggregation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07608120: Electrolyte Beverage Combined With Polyethylene Glycol for Colonoscopy Bowel Preparation

    Sponsor: Nanfang Hospital, Southern Medical University. Phase: NA. Conditions: Colonoscopy, Bowel Preparation Solutions, Colorectal Cancer Screening

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05948020: Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria

    Sponsor: Children's Hospital of Fudan University. Phase: EARLY_PHASE1. Conditions: Phenylketonuria

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06988020: "Pseudo-scanner" MRI Sequences for the Detection of Bone Lesions in Multiple Myeloma

    Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Phase: NA. Conditions: Multiple Myeloma Bone Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07033182: Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment

    Sponsor: Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd. Phase: PHASE1. Conditions: Infections Caused by Anaerobic Bacteria, Renal Impairment

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07675382: WB-EMS and Diet Effects on Body Composition, Cardiometabolic Markers, and Myokines in Obese Women

    Sponsor: Firat University. Phase: NA. Conditions: Obesity

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07427082: Comparison of Lumbar Erector Spinae Plane Block and Spinal Anesthesia in Hip and Proximal Femur Surgery

    Sponsor: Gaziantep City Hospital. Phase: NA. Conditions: Hip Surgery, Femoral Neck Fractures

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06876259: Artificial Intelligence Diagnostic Decision Support to Reduce Antimicrobial Prescriptions in Young Children With Colds

    Sponsor: Timothy Shope. Phase: NA. Conditions: Acute Otitis Media (AOM), Upper Respiratory Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04961580: PK/PD of Ceftazidime Avitbatan Sodium in Children With Severe Infection

    Sponsor: Children's Hospital of Fudan University. Phase: . Conditions: Sepsis, Antibiotic Reaction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07271979: Liposomal Bupivacaine Versus Ropivacaine for Preperitoneal Infiltration Analgesia in Upper Abdominal Laparotomy

    Sponsor: Qilu Hospital of Shandong University. Phase: NA. Conditions: Liposomal Bupivacaine, Preperitoneal Infiltration, Analgesia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04787679: Image-guided Computational and Experimental Analyses of Fractured Patient's Bone (GAP)

    Sponsor: Laura Maria Vergani. Phase: . Conditions: Osteoporosis, Fragility Fracture

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06527079: Evaluation of Clinical Decision Support in Opioid Tapering

    Sponsor: University of Colorado, Denver. Phase: . Conditions: Medication Abuse, Harm Reduction, Opioid Use Disorder, Opioid Prescribing, Opioid Overdose, Prevention

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06073379: Efficacy of Korean Manupuncture on Pain in Women With Endometriosis: a Parallel-group Randomized Controlled Trial

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: NA. Conditions: Endometriosis, Pain

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07275359: Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations

    Sponsor: Duke University. Phase: PHASE1. Conditions: Chronic Obstructive Pulmonary Disease (COPD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06661980: Dexmedetomidine on Brain Injury Patients

    Sponsor: Damanhour University. Phase: NA. Conditions: Brain Injuries

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06499896: Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC)

    Sponsor: Diwakar Davar. Phase: PHASE2. Conditions: Immune-mediated Colitis (IMC), Immune-related Dermatitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07630662: Effectiveness of Diaphragmatic Function and Parasternal Intercostal Muscles Functions as Predictors for Successful Weaning From Mechanical Ventilation

    Sponsor: Ain Shams University. Phase: . Conditions: Ventilated Patient in Intensive Care

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07039162: Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma

    Sponsor: Ming-Yu Lien. Phase: PHASE2. Conditions: Esophageal Squamous Cell Carcinoma (ESCC), Locally Advanced Unresectable Esophageal Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03864562: Gastric Emptying - Implications for the Pathogenesis of Type 2 Diabetes

    Sponsor: University of Nottingham. Phase: . Conditions: Diabetes Mellitus, Type 2

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03089346: Assessment of Bronchial Thickness Using MRI in Asthma

    Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Asthma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07497503: A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants

    Sponsor: Syneos Health. Phase: PHASE1. Conditions: Healthy Volunteers

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03748303: Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study

    Sponsor: University of Arizona. Phase: PHASE1. Conditions: Alzheimer Dementia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07354750: Effect of Parasternal Plane Block on Intraoperative Nociception

    Sponsor: Diskapi Yildirim Beyazit Education and Research Hospital. Phase: NA. Conditions: Median Sternotomy, Pain Management

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07565350: Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts

    Sponsor: First Hospital of China Medical University. Phase: NA. Conditions: Refactory Warts

    full page →ctgov ↗
    ← prev
    page 102 of 104
    next →